The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g Vct5 Regulatory News (MIG5)

Share Price Information for Maven I&g Vct5 (MIG5)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 30.40
Bid: 29.40
Ask: 31.40
Change: 0.00 (0.00%)
Spread: 2.00 (6.803%)
Open: 30.40
High: 30.40
Low: 30.40
Prev. Close: 30.40
MIG5 Live PriceLast checked at -
Maven Income and Growth VCT 5 is an Investment Trust

To invest in a diversified portfolio of later-stage UK private companies to provide long-term capital appreciation and generate maintainable levels of income for shareholders.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of a Prospectus

7 Oct 2022 16:28

RNS Number : 2322C
Maven Income & Growth VCT PLC
07 October 2022
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY JURISDICTION FOR WHICH THE SAME COULD BE UNLAWFUL. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE AN OFFER OF SECURITIES FOR SALE IN ANY JURISDICTION, INCLUDING IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA.

 

Joint Announcement by Maven Income and Growth VCT PLC, Maven Income and Growth VCT 3 PLC, Maven Income and Growth VCT 4 PLC and Maven Income and Growth VCT 5 PLC

Offers for Subscription

7 October 2022

 

The Board of Directors of Maven Income and Growth VCT PLC, Maven Income and Growth VCT 3 PLC, Maven Income and Growth VCT 4 PLC and Maven Income and Growth VCT 5 PLC (together the "Companies" and each a "Company") are pleased to announce that they have published a joint Prospectus (comprising a Securities Note, Registration Document and Summary) in relation to offers for subscription for new Ordinary Shares of 10p each in each of the Companies to raise, in aggregate, up to £40 million, including over-allotment facilities of up to, in aggregate, £10 million (before issue costs) (the "Offers" and each an "Offer").

The Companies have also published a joint Circular (the "Circular") seeking the approval of their respective shareholders for the allotment and disapplication authorities in connection with the Offers and each Company giving notice of a General Meeting to be held on 9 November 2022 (the "General Meeting").

The Offers will open on 7 October 2022 and the deadline for receipt of applications is 12.00 noon on 4 April 2023 in relation to the tax year 2022/23 and 12.00 noon on 26 May 2023 in relation to the tax year 2023/24. The Offers will close on 31 May 2023 unless the relevant Offer is fully subscribed by an earlier date or previously extended by the relevant Board to no later than 6 October 2023

Each Offer is conditional on the passing of certain resolutions at the relevant General Meeting.

Pursuant to individual offer agreements dated 7 October 2022 relating to each Offer between, among others, each relevant Company and Maven Capital Partners LLP ("Maven"), Maven, as the administrator of each Offer, will receive an offer administration fee of 2.5% of the application amount in relation to each accepted application, with reductions to the offer administration fee applying for applications that benefit from an Early Investment Incentive discount, or as may otherwise be waived by Maven. Maven, as the investment manager of each Company, is a related party of each Company under the Listing Rules, and the payment of such a fee by the Company to Maven is a transaction to which Listing Rule 11.1.10R applies.

To obtain a copy of the Securities Note, private investors and financial advisers should call Maven on 0141 306 7400. A downloadable version of the Securities Note will shortly be available from the Maven website: www.mavencp.com/vctoffer.

Copies of the Prospectus and Circular are available, free of charge, from Maven at Kintyre House, 205 West George Street, Glasgow G2 2LW.

Copies of the Prospectus have been submitted to the National Storage Mechanism and will shortly be available for viewing online at the following website address: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

Any enquiries in respect of the Offers should be directed to:

Maven Capital Partners UK LLPTelephone: 0141 306 7400

E-mail: enquiries@mavencp.com

The information contained within this announcement is deemed by the Companies to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014). Upon the publication of this announcement via Regulatory Information Service this inside information is now considered to be in the public domain.

 

Notes

 

This announcement does not constitute or form part of any offer to issue or sell, or any solicitation of any offer to subscribe or purchase, any investment in any jurisdiction, nor shall it (or the fact of its distribution) form the basis of, or be relied on in connection with, any contract therefor.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PDIZZMGGKNVGZZM
Date   Source Headline
26th Jul 201311:26 amRNSDirector/PDMR Shareholding
26th Jul 20137:00 amRNSHalf Yearly Report
25th Jul 201310:47 amRNSNet Asset Value(s)
24th Jul 201310:50 amRNSNet Asset Value(s)
23rd Jul 201311:51 amRNSNet Asset Value(s)
22nd Jul 201310:29 amRNSNet Asset Value(s)
19th Jul 201311:13 amRNSNet Asset Value(s)
18th Jul 201312:00 pmRNSNet Asset Value(s)
17th Jul 201311:35 amRNSNet Asset Value(s)
16th Jul 201311:13 amRNSNet Asset Value(s)
15th Jul 201312:46 pmRNSNet Asset Value(s)
12th Jul 201311:11 amRNSNet Asset Value(s)
11th Jul 201310:55 amRNSNet Asset Value(s)
10th Jul 201311:20 amRNSNet Asset Value(s)
9th Jul 201311:07 amRNSNet Asset Value(s)
8th Jul 201311:04 amRNSNet Asset Value(s)
5th Jul 201310:23 amRNSNet Asset Value(s)
4th Jul 201312:25 pmRNSNet Asset Value(s)
3rd Jul 201311:04 amRNSNet Asset Value(s)
2nd Jul 201311:06 amRNSNet Asset Value(s)
1st Jul 201311:38 amRNSNet Asset Value(s)
28th Jun 201311:26 amRNSNet Asset Value(s)
27th Jun 201310:44 amRNSNet Asset Value(s)
26th Jun 201312:32 pmRNSNet Asset Value(s)
25th Jun 201310:51 amRNSNet Asset Value(s)
24th Jun 201311:50 amRNSNet Asset Value(s)
21st Jun 201312:28 pmRNSNet Asset Value(s)
20th Jun 201310:51 amRNSNet Asset Value(s)
19th Jun 201312:31 pmRNSNet Asset Value(s)
18th Jun 20132:26 pmRNSChange of Registered Office
18th Jun 201311:38 amRNSNet Asset Value(s)
17th Jun 201311:50 amRNSNet Asset Value(s)
14th Jun 201312:44 pmRNSNet Asset Value(s)
13th Jun 201312:23 pmRNSNet Asset Value(s)
12th Jun 201310:19 amRNSNet Asset Value(s)
11th Jun 20131:37 pmRNSNet Asset Value(s)
10th Jun 201310:53 amRNSNet Asset Value(s)
7th Jun 201311:52 amRNSNet Asset Value(s)
6th Jun 20132:49 pmRNSNet Asset Value(s)
5th Jun 20131:22 pmRNSNet Asset Value(s)
4th Jun 201311:54 amRNSNet Asset Value(s)
3rd Jun 20132:31 pmRNSNet Asset Value(s)
3rd Jun 20137:00 amRNSDirectorate Change
31st May 201312:18 pmRNSNet Asset Value(s)
30th May 201312:28 pmRNSNet Asset Value(s)
29th May 201310:55 amRNSNet Asset Value(s)
28th May 201311:37 amRNSNet Asset Value(s)
24th May 201311:18 amRNSNet Asset Value(s)
23rd May 201312:55 pmRNSNet Asset Value(s)
22nd May 20131:56 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.